Introduction
Prevalence of epilepsy in the general population is approximately 0.7%. Most patients with epilepsy respond well to drug treatment [1] [2] [3] ; however, 20-30% of them are refractory to pharmacological therapy. In this patient population, alternative treatments such as surgical resection or deep brain stimulation (DBS) should be considered. Temporal lobe epilepsy (TLE) is the most frequent focal epileptic syndrome and is often associated with pharmacoresistance. Resection of mesial temporal structures, either selective or associated with anterior temporal lobectomy, can lead to seizure freedom in more than 70% of cases. 4, 5 Unfortunately, up to 30% of TLE are unsuitable for surgery; either because of the bilateral nature of the disease or because of concerns for major post-operative verbal memory loss after removal of the amygdalo-hippocampal complex. 6 This is particularly true for patients with non-lesional left TLE. 7 In these cases, DBS of the amygdala-hippocampal complex (AH) has been proposed as a therapeutic alternative. This consists of continuous or intermittent electrical stimulation, using pulses which have a defined form, frequency, width, voltage and stimulation configuration. AH-DBS has been reported in twenty-two TLE The objective of this study was to evaluate the efficiency and the effects of changes in parameters of chronic amygdala-hippocampal deep brain stimulation (AH-DBS) in mesial temporal lobe epilepsy (TLE).
Eight pharmacoresistant patients, not candidates for ablative surgery, received chronic AH-DBS (130 Hz, follow-up 12-24 months): two patients with hippocampal sclerosis (HS) and six patients with non-lesional mesial TLE (NLES). The effects of stepwise increases in intensity (0-Off to 2 V) and stimulation configuration (quadripolar and bipolar), on seizure frequency and neuropsychological performance were studied.
The two HS patients obtained a significant decrease (65-75%) in seizure frequency with high voltage bipolar DBS (!1 V) or with quadripolar stimulation. Two out of six NLES patients became seizure-free, one of them without stimulation, suggesting a microlesional effect. Two NLES patients experienced reductions of seizure frequency (65-70%), whereas the remaining two showed no significant seizure reduction. Neuropsychological evaluations showed reversible memory impairments in two patients under strong stimulation only.
AH-DBS showed long-term efficiency in most of the TLE patients. It is a valuable treatment option for patients who suffer from drug resistant epilepsy and who are not candidates for resective surgery. The effects of changes in the stimulation parameters suggest that a large zone of stimulation would be required in HS patients, while a limited zone of stimulation or even a microlesional effect could be sufficient in NLES patients, for whom the importance of the proximity of the electrode to the epileptogenic zone remains to be studied. Further studies are required to ascertain these latter observations. ß 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
patients so far. [8] [9] [10] Overall, the results have shown a beneficial effect.
Out of these twenty-two patients, five became seizure free; ten patients benefited from a seizure reduction frequency of at least 50%; six patients showed a reduction of less than 50%; one patient experienced an increase in seizure frequency. In this group, high frequency stimulations, 130 or 190 Hz, with a pulse width of 90 or 450 ms, were applied, either continually or cyclically. From these studies, it appears that high frequency DBS is efficient in a significant portion of the patient population (15/22; 68%); however, the effects of stimulation parameters were not addressed.
Here, we present long-term results of eight patients treated with unilateral chronic AH-DBS as anti-epileptic treatment of TLE, with a particular emphasis on the influence of certain DBS parameters such as the amplitude and stimulation configuration (quadripolar or bipolar).
Methods

Patients
Eight patients with intractable TLE epilepsy were treated with unilateral DBS in the mesial temporal structures between June 2002 to April 2008 (five females and three males, median age: 31.5 years, range: 25-47; Table 1 ). All patients underwent a comprehensive work-up, in order to determine if they were candidates for surgery. This included 3T brain MRI with a state-of-the-art epilepsy protocol, video-EEG telemetry, interictal positron emission tomography (PET), ictal and interictal single photon emission computerized tomography (SPECT), as well as neuropsychological and psychiatric assessments. All patients, except Pt9, also underwent an intra-arterial amobarbital test with selective injection into the anterior choroidal artery in order to rule out major post-operative verbal memory deficit post-operatively.
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Five patients, Pt4-Pt9, underwent additional intracranial invasive monitoring with stereotactic depth electrodes in both temporal lobes. Depth electrodes were inserted perpendicularly to the surface allowing the recording of the amygdala, the anterior and/or the posterior hippocampus.
The decision to proceed with DBS rather than resective surgery was based on the following observations: (1) bilateral epileptogenic zones (EZ) with or without predominance on one side and (2) concern over possible post-operative worsening of (verbal) memory. Patient data and results of the preoperative work-up are shown in Table 1 . Due to the fact that most patients with hippocampal sclerosis benefit from resective surgery, only two patients with hippocampal sclerosis were available for the present study. The remaining six patients had non-lesional TLE as determined by high-resolution MRI. All patients had baseline MRI scans acquired with a 1.5T (Pts1-5, 8) or 3T (Pts7, 9) scanner.
In the two patients with hippocampal sclerosis (Pt1-left and Pt2-right), implantation was performed in the sclerotic hippocampus which was also the site of the seizure onset zone. In cases of non-lesional TLE, the side of the unilateral DBS was chosen based on the seizure onset zone determined through an invasive exploration (Pt5-right; Pt4, Pt7, Pt8 and Pt9-left; non-invasive exploration in Pt3-right).
All subjects gave their informed consent to participate in the study, conducted according to the recommended ethical guidelines of the Declaration of Helsinki, and approved by the local Ethics Committee of the University Hospitals of Geneva and Lausanne.
Implantation procedure of DBS electrodes and neurostimulators
A 3D T1-weighted MRI was acquired under stereotactic conditions (CRW, Radionics 1 , Burlington, MA, USA). 3D surgical planning was performed on the Framelink stereotactic software (Medtronic, Minneapolis, MN, USA). The trajectory was planned along the main axis of the hippocampus at the junction between the hippocampus and the parahippocampal gyrus in order to avoid the temporal horn of the ventricle and/or choroidal fissure. In the operating room, the patient was positioned in a semi-sitting position. A U-shaped skin incision was performed under local anesthesia in the occipital region precisely determined by the entry point of the planned trajectory. The skull was opened with an 8 mm twist-drill. The dura was carefully perforated with coagulation to avoid significant CSF leakage and the electrode was implanted under lateral fluoroscopic control. The tip of the DBS electrode was directed in the upward direction so that the distal contact(s) could be implanted within the amygdala, whereas the more proximal contacts could be placed along the anteroposterior axis of the hippocampus. External extension was performed to provide EEG recordings for three or four days before internalisation. The day following the implantation procedure, a postoperative 3D T1 weighted MRI was performed. In cases where the contacts of the electrode were not clearly identifiable, due to the artefacts, a high resolution CT scan was co-registered with the preoperative 3D T1-weighted MRI to allow precise localisation of the electrode contacts. Finally, at day three or four postimplantation, the stimulator was placed in the ipsilateral subclavicular space under general anesthesia. The five first patients received the Pisces-Quad, 3487A, electrode and the Soletra, 7426 stimulator (Medtronic Inc, Minneapolis, MN, USA). Each contact of the Pisces-Quad electrode has a cylinder shape (3 mm length, 1.27 mm diameter). The electrode has four contacts and the distance between contacts is 6 mm. The electrode is 30 mm in total length.
The last three received the Sub Compact Octad, 3876, electrode and the Restore stimulator (Medtronic Inc, Minneapolis, MN, USA). Each contact of the Sub Compact Octad electrode has a cylinder shape (3 mm length, 1.27 mm diameter). The electrode has 8 contacts and the distance between contacts is 1.5 mm. The electrode is 34.5 mm in total length.
The Soletra and the Restore neurostimulators are voltage source stimulators and the amplitudes of stimulation are given in volts. They produce pseudo monophasic charge balanced pulses: a high amplitude, short duration and cathodic (negative) phase, precedes a low amplitude, long duration and anodic (positive) phase. 12 These neurostimulators are capacitively coupled to prevent neurotoxic effects due to residual constant DC charge that occurs with charge unbalanced pulses. 13 
Stimulation parameters and follow-up
The patients were stimulated for at least three months with each of the different parameters set at a given value, i.e., for each amplitude tested. At the end of each period, the patients were seen by the neurologist in order to evaluate the effects of the stimulation. DBS was delivered continuously (no On/Off stimulation cycles of minutes or seconds), in all cases with a frequency of 130 Hz. Pulse width was 0.45 ms.
DBS was applied initially in a quadripolar configuration systematically for the first six patients without consideration of the intracranial EEG (Pt1-Pt7). In this configuration, the four contacts were set as cathodes and the case box of the neurostimulator was set as the anode. In addition to quadripolar configuration, DBS was applied in bipolar configuration to evaluate effects of a small zone of stimulation in all patients. One contact was set as a cathode and the other one as an anode. The cathode was set on the contact adjacent to the most epileptogenic site, determined by the highest amplitude and most frequent interictal spikes noted when intracranial EEG was performed through the implanted electrode, before the internalisation of the neurostimulator. The anode was set on the contact closest to the second major interictal epileptogenic site. When the neurostimulator was implanted (Pt7-Pt9) or when it had to be changed because the battery was discharged (Pt1-Pt4), the subjects were observed for three months without stimulation, referred to as off-time in this study.
The numbers of seizures per month were established. The preimplantation baselines were determined prospectively as the mean number of seizures per month averaged over the last three months before implantation and did not include presurgical evaluation time. In both HS patients, the increases in seizure rates were most intense at the time the batteries were discharged, thus the seizure count of Off periods began with a noticeable increase. In the cases of NLES TLE, changes in seizure rates were not associated with battery discharges, thus we began the seizure count at the time the neurostimulator was interrogated and that showed the battery was discharged. In all cases, the stimulators were turned on as soon as they were implanted again, usually three months after the interrogation of the neurostimulator that showed the battery was discharged.
Major drug changes were avoided after implantation in order to estimate the effect of DBS. Minor changes of drug dosages were accepted but introduction of any new antiepileptic drug was not allowed and one patient, Pt6, was excluded from the study for this reason.
All patients received a neuropsychological assessment during follow-up with an emphasis on memory testing in verbal and visuospatial modalities in view of the implantation sites. Verbal and visual long and short-term memory were tested using the Rey Auditory-Verbal Learning Task (RAVLT), the Rey Visual Design Test (RVDT), and the Verbal and Visuospatial Supraspan. 14, 15 For the RAVLT and the RVDT, two indices were used, namely the sum of items reproduced during the five learning sessions, and the number of items recalled after 40 min after the last learning session (delayed recall). For the verbal and visuo-spatial spans, the maximum number of elements correctly reproduced in the direct order was considered as the span. These values were referred to the norms for persons of the same sex, age group and level of education. Scores falling between the 2nd and 5th percentile were considered impaired (I), while scores below the 2nd percentile were deemed severely impaired (SI). Performances above the 5th percentile were considered normal (N).
Results
Localisation of the electrode contacts and complications of surgical procedure
All eight patients were implanted unilaterally with one electrode in the amygdalo-hippocampal complex as described in the protocol described above (three on the right side: Pt2, Pt3, Pt5; five on the left side: Pt1, Pt4, Pt7, Pt8, Pt9).
No haemorrhagic or infectious complication was observed in this patient cohort. Displacement of the electrode occurred in Pt5 during the stimulator implantation procedure, necessitating reimplantation. The contacts assigned to the EZ were located at the anterior part of the hippocampus (Pt1, Pt7, Pt8), at the junction of the anterior hippocampus and of the parahippocampal gyrus (Pt2-Pt4) or at the mid-superior and posterior hippocampus (Pt9).
Although we did not observe any complication of AH-DBS resulting from cerebral haemorrhage or infection, one patient needed to be reimplanted because of an electrode displacement, resulting from an involuntary traction on the electrode. In another patient, a fracture of the electrode was identified just proximal to a titanium miniplate used for its fixation to the skull. Titanium miniplates were abandoned in subsequent cases.
Effects of AH-DBS on seizure frequency
The patients were followed up between 12 and 74 months (median: 43.5 months). Fig. 1 describes the changes in complex partial seizure (CPS) frequencies observed for the different DBS parameters. Changes in seizure frequencies were compared to the pre-implantation baseline: À100% means the patient was seizure free; +100% indicated the seizure frequency doubled and 0% means the seizure frequency remained unchanged. Means and standard errors were computed when monthly seizure frequencies could be calculated.
The two HS patients, Pt1 and Pt2 showed significant reductions in seizure frequencies with the quadripolar configuration (1 V), i.e., À67% and À88% respectively (both patients began using these parameters one year after implantation and subsequently continued for three years). If a bipolar configuration was used, seizure reduction was obtained only if at least 1 V was applied (this was Fig. 1 . Changes in seizure frequencies with DBS parameters compared to the pre-implantation baseline: À100% means the patient was seizure free; +100% means the seizure frequency doubled and 0% means the seizure frequency did not change. Means and standard errors were computed when monthly seizure frequencies could be calculated. Results are analyzed for both groups of patients with either LES or NLES TLE. Quadripolar configuration (Quad); stimulation off (Off); amplitudes of bipolar configurations are indicated in volts (0.5-2 V); seizure free patients (*); memory worsening (**).
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only carried out for a few months after several years of stimulation). However with low amplitude bipolar stimulation (0.5 V) or during off periods, both patients experienced a significant increase in seizure frequency. For Pt1, secondary generalized seizures disappeared right after implantation and first stimulation (2 V, quadripolar for the first year).
Two out of six NLES patients became seizure free, Pt5 and Pt9. Pt9 was seizure free two months after the electrode implantation and without stimulation (the two final seizures were observed during the first two months post implantation). No sign of either macroscopic haemorrhage or microlesion (hypointensity on T1-weighted images) could be identified on the postoperative MRIs. However, the artifact induced by the electrode could have masked a possible microlesion occurring within 1-3 mm around the electrode. Pt5 became seizure free with a bipolar configuration (1 V), but not with the previous quadripolar configuration (he initially used this quadripolar configuration during six months and then the bipolar configuration for three years).
In two other patients, Pt3 and Pt4, major seizure reductions of À72 and À84%, respectively, were observed. Pt3 experienced this reduction with quadripolar configuration (0.5 V, during the first year), and Pt4 with bipolar configuration (0.5 V, one year post implantation and then for years). Higher bipolar voltages of up to 1.5 or 2 V did not improve seizure occurrence in Pt3 or in Pt4, respectively (tested over one year). In Pt3, bipolar stimulation increase to 2.5 V was immediately followed by a typical complex partial seizure. This effect could be reproduced and confirmed with video-EEG monitoring. The DBS parameters were reverted to their previous values and she returned to her previous seizure frequency. Pt3 and Pt4 did not experience any significant increase in seizures during an off-period of three months observed at the time the neurostimulator had to be changed because of battery discharge (i.e., after three years of DBS).
No significant reductions in seizure frequencies were observed in the remaining two NLES patients, Pt7 and Pt8. Pt7, experienced his largest decrease in seizure frequencies, À28%, while using bipolar configuration (1 V, first six months). Lower intensity (0.5 V) or quadripolar configurations did not improve his condition. Pt8 did not experience any significant seizure reduction either during his initial off period or with bipolar stimulation (1.5 V).
Neuropsychological evaluation
Verbal and visual memory was tested formally pre-and postimplantation in five patients, Pt1, Pt3, Pt4, Pt7 and Pt9. The other three patients were unwilling to travel to the hospital and declined post-implantation neuropsychological assessment. Performances are summarized in Table 1 . As noted in Section 2, the performances on the sum of the 5 trials on the RAVLT and RDVT were considered normal if they fell above the 5th percentile with respect to the control population (indicated by the letter N in Table 1) . A performance between 2 and 5th percentile was considered a moderate impairment (MI) while a score below the 2nd percentile was a severe impairment (SI). The letters in parentheses correspond to the performance in the delayed recall of the task.
In three out of the five participating patients, Pt1, Pt4 and Pt9, post-operative verbal memory scores were similar to the preoperative ones. In Pt3 however, visual delayed recall became impaired when the patient was stimulated with 2 V (**bipolar stimulation, Fig. 1 ). This was reversed after switching to lower stimulation amplitudes. For Pt7, both visual and verbal memory fell below the 5th percentile for immediate and delayed recall when using the quadripolar stimulation (**quadripolar stimulation, Fig. 1 ). Visual memory returned within the norm using bipolar configuration.
When psychiatric assessments could be performed (Hospital Anxiety and Depression Scale 16 and psychiatric interview), no change was reported (Pt1, Pt3, Pt4, Pt7 and Pt9; Table 1 ).
Discussion
The present long-term study of AH-DBS, with a follow-up of up to 74 months, showed the variable efficiency of AH-DBS hereby observed in TLE, in accordance with previous studies. [8] [9] [10] No irreversible cognitive impairments or psychiatric impairments were encountered. Thus long-term AH-DBS appears to be a safe procedure. The analysis of changes in stimulation parameters suggests that DBS must be tailored individually and that stimulation parameters should also be taken into account when considering the efficacy of AH-DBS. Both HS patients required a strong stimulation (high stimulus amplitude, at least 1 V, or/and multipolar configuration) in order to decrease the seizure frequency. Indeed, when the amplitude of the bipolar stimulation was lower than 1 V, seizure frequency increased. Similar observations have been reported by other authors in this subgroup of patients. One of the two HS patients in the study of Boon et al. 10 became seizure free with high amplitude stimulation (2-3 V). In addition, they used two contacts as cathodes and the case box as an anode, i.e., stimulating a large zone. Velasco et al. 9 used bipolar configurations in their HS patients at the site of the EZ and small amplitudes of stimulation. This configuration did not produce a reduction in seizure frequency in HS patients as that in NLES patients. Tellez-Zenteno et al. 8 observed variable effects in four HS patients, ranging from an increase in seizures to reduction of about 65%, with no seizure free patient. They used quadripolar configuration and high voltages between 1.8 and 4 V, which could have produced excitatory effects, possibly limiting the efficiency of DBS. Taken together, these findings suggest that a large zone (produced by high amplitude of stimulation or multipolar configuration), needs to be stimulated in HS patients in order to obtain a reduction in seizure frequency. However this should be done by progressing with a stepwise increase to maximal values at about 2 V. During off-periods, increases in seizure frequency above prestimulation levels were observed in our study. This was also reported in two patients studied by Tellez-Zenteno et al., 8 and for one patient in Velasco et al. 9 The seizure increase could be due to a natural deterioration in the course of the disease, which might be masked by stimulation. Four NLES patients benefitted significantly from unilateral AH-DBS. A curative microlesional effect may have occurred in one patient. Microlesional effects have been reported in few epileptic patients following diagnostic implantation of depth electrodes in the temporal lobe 17, 18 as well as in the field of DBS related to movement disorders. 19 A suppression of seizures with a small zone of stimulation (low amplitude), was observed in one patient. Velasco et al. 9 obtained several seizure free patients with low stimulation amplitudes (low current in bipolar configuration) after a short period of stimulation (about two months). In two NLES patients, no significant difference in seizure reductions was observed between bipolar and quadripolar configurations, while applying low amplitudes of stimulation (maximum of 1 V). Boon et al. 10 did not obtain NLES seizure-free patients with 2 or 3 V stimulation. In one of our cases, habitual complex partial seizures were even reliably provoked when intensity was increased up to 2.5 V. Finally, significant differences in seizure reduction were not noted between Off and On periods. A lack of effect was observed in two NLES patients. In these cases, the electrode might have been too distant from the primary EZ. In one case, the non-response may have been due to the fact that one EZ had been identified in the superior and posterior part of the temporal lobe, in addition to another in the mesial structures. It is possible that the latter may have been involved only as a secondary EZ. One main parameter could be the electrode distance from the primary EZ, knowing the EZ can be very limited. 20 In NLES patients, although invasive recordings suggested a participation of mesial structures, the exact EZ may not have been clearly identified in all patients. The efficiency of AH-DBS in this subgroup might be linked to the correlation between the localisation of the EZ and of the electrode. In some NLES patients the stimulation of the mesial structures may have produced only a modulation of the neuronal activity involved in the epileptogenic network with a primary EZ localised outside the mesial structures.
In the present study, all patients were implanted unilaterally. It is possible that, in our group of NLES patients presenting bilateral ictal involvement, bilateral DBS would have produced an improvement. Indeed, the chances of modulating the neuronal activity involved in the epileptogenic network may increase remarkably for bilateral implantations, as reported by Velasco et al. 9 Up to now, there are no large studies investigating the cognitive effects of DBS in patients with epilepsy. Pre-operatively, the neuropsychological picture in DBS was similar to that observed in TLE with hippocampal sclerosis or atrophy, showing namely predominance in memory deficits. [21] [22] [23] [24] Post-operatively, there was no significant memory decrease in our patients, suggesting that the insertion of an electrode in the hippocampus does not damage the structures significantly. In two patients, impairments were noted only when stimulation occurred over a large volume (quadripolar configuration or high intensity). In both cases, the cognitive decline was completely reversible after returning to previous DBS parameters, indicating its functional nature. Close monitoring of clinical DBS effects, with short intervals between neuropsychological evaluations (e.g., every three or four months), seems mandatory.
In conclusion, AH-DBS appears to be a valuable option for patients who suffer from pharmacoresistant mesial TLE in whom ablative surgery is contra-indicated. It is safe and efficient in the majority of patients. NLES patients are less likely to be operated, in particular when the focus resides in the language dominant hemisphere, due to concerns of major verbal memory deficits, making them more eligible for DBS. The stimulation parameters of the AH-DBS must be monitored very carefully, since high amplitudes of stimulation may be associated with a reversible worsening of memory function and can even provoke seizures. Finally, the optimal parameters of stimulation appear to be different for HS and for NLES patients.
Conflict of interest statement
None of the authors has any conflict of interest to disclose.
